A Preliminary Results of a Randomized Trial Comparing Monthly 5-flourouracil and Cisplatin to W eekly Cisplatin A lone Combined with Concurrent Radiotherapy for Locally Advanced Cervical Cancer
Cancer Research and Treatment. 2005;37(1):37 
8512 POSTER DISCUSSION A Three-Arm Randomized Trial Comparing Neo-Adjuvant or Concurrent Weekly Cisplatin to Radiotherapy Alone for Locally Advanced Head and Neck Squamous Cell Cancer (HNSCC)
European Journal of Cancer. 2011;47:S547
Combined postoperative radiotherapy and weekly cisplatin infusion for locally advanced head and neck carcinoma: final report of a randomized trial
Cancer/Radiothérapie. 1997;1(3):265-266
Concurrent cisplatin-based radiotherapy and chemotherapy for locally advanced cervical cancer
Cancer/Radiothérapie. 1999;3(4):345-347
Prospective randomized comparison of monthly fluorouracil and cisplatin versus weekly cisplatin concurrent with pelvic radiotherapy and high-dose rate brachytherapy for locally advanced cervical cancer
Gynecologic Oncology. 2008;108(1):195-200
166 poster A pilot phase II trial with Cisplatin — Paclitaxel treatment and concurrent external and endocavitary radiotherapy in locally advanced cervical cancer
Radiotherapy and Oncology. 2004;71:S78
240 Oral A randomized phase II study comparing concurrent versus sequential radiochemotherapy with vinorelbine and cisplatin (v-p) in locally advanced non-small cell lung cancer
Radiotherapy and Oncology. 2002;64:S81
Concurrent radiotherapy with S-1 plus cisplatin versus concurrent radiotherapy with cisplatin alone for the treatment of locally advanced cervical carcinoma: a pilot randomised controlled trial
Clinical and Translational Oncology. 2015;18(4):413-417
Concurrent weekly single cisplatin vs triweekly cisplatin alone with radiotherapy for treatment of locally advanced cervical cancer: a meta-analysis
Cancer Management and Research. 2018;Volume 10:1975-1985
1001 POSTER Neoadjuvant docetaxel (taxotere) and cisplatin followed by concurrent cisplatin-radiotherapy in locally advanced nasopharyngeal carcinoma: a randomized phase II study
European Journal of Cancer Supplements. 2005;3(2):288